Medical device company Renovis Surgical Technologies closed a $3.5 million funding round through sales of equity financing, according to an SEC filing.
The Redlands, Calif.-based company raised the funds from 15 investors, 4 of which did not qualify as accredited investors, but none of which were named in the filing.
Renovis develops orthopedic technologies for spine, adult joint reconstruction and trauma surgery. The company last month won FDA clearance for its A200 knee replacement system, according to an FDA notice.